NCT07039916 - Study to Access the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis | Biotech Hunter

Enrollment

231

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG

IMVT-1402

• Dose 1 subcutaneous (SC) once weekly (QW) for 12 weeks (Period 1)

DRUG

IMVT-1402

"* Dose 2 SC QW for 12 weeks (Period 1)~* Dose 2 SC QW for 14 weeks (Period 2)"

DRUG

Placebo

• Placebo SC QW for 12 weeks (Period 1)

DRUG

IMVT-1402

• Dose 1 SC QW for 14 weeks (Period 2)

Trial Locations (25)

10065

RECRUITING

Site Number - 1034, New York

20010

RECRUITING

Site Number - 1024, Washington D.C.

22903

RECRUITING

Site Number - 1009, Charlottesville

27599

RECRUITING

Site Number - 1020, Chapel Hill

27710

RECRUITING

Site Number - 1013, Durham

29486

RECRUITING

Site Number - 1015, Charleston

30329

RECRUITING

Site Number - 1014, Atlanta

32174

RECRUITING

Site Number - 1037, Ormond Beach

33612

RECRUITING

Site Number - 1007, Tampa

33761

RECRUITING

Site Number - 1006, Clearwater

33952

RECRUITING

Site Number - 1002, Port Charlotte

40356

RECRUITING

Site Number - 1032, Nicholasville

48824

RECRUITING

Site Number - 1005, East Lansing

73099

RECRUITING

Site Number - 1011, Yukon

75206

RECRUITING

Site Number - 1003, Dallas

80528

RECRUITING

Site Number - 1027, Fort Collins

85028

RECRUITING

Site Number - 1017, Phoenix

85251

RECRUITING

Site Number - 1025, Scottsdale

90033

RECRUITING

Site Number - 1023, Los Angeles

92011

RECRUITING

Site Number - 1010, Carlsbad

92270

RECRUITING

Site Number - 1029, Rancho Mirage

92697

RECRUITING

Site Number - 1028, Irvine

94143

RECRUITING

Site Number - 1004, San Francisco

97477

RECRUITING

Site Number - 1031, Eugene

07512

RECRUITING

Site Number - 1019, Totowa